ANIX: Anixa Biosciences, Inc. Stock

by  •  • Comments Off on ANIX: Anixa Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 94.01
Enterprise Value ($M) 91.63
Book Value ($M) 18.89
Book Value / Share 0.59
Price / Book 4.98
NCAV ($M) 18.66
NCAV / Share 0.58
Price / NCAV 5.04

Profitability (mra)
Return on Invested Capital (ROIC) -0.66
Return on Assets (ROA) -0.49
Return on Equity (ROE) -0.53

Liquidity (mrq)
Quick Ratio 8.54
Current Ratio 8.54

Balance Sheet (mrq) ($M)
Current Assets 21.36
Assets 21.59
Liabilities 2.70
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -13.83
Net Income -12.55
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -7.33
Cash from Investing 4.28
Cash from Financing 3.42

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-03 13D/A Kumar Amit 15.10 15.74
05-03 13D Catelani Michael 5.25

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-01-10 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-09-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-06-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 16,264 43,016 37.81
2025-03-06 6,662 25,873 25.75
2025-03-05 19,057 38,655 49.30
2025-03-04 18,234 64,467 28.28

(click for more detail)

Similar Companies
ALVR – AlloVir, Inc. ALZN – Alzamend Neuro, Inc.
ANEB – Anebulo Pharmaceuticals, Inc. APM – Aptorum Group Limited
APRE – Aprea Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io